niflumic acid has been researched along with Inflammation in 10 studies
Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Morniflumate has a 30-year history of clinical use, particularly for the treatment of pain associated with paediatric ENT infection." | 6.52 | Efficacy and safety of morniflumate for the treatment of symptoms associated with soft tissue inflammation. ( Cavalieri, L; Cremonesi, G, 2015) |
| "Morniflumate has a 30-year history of clinical use, particularly for the treatment of pain associated with paediatric ENT infection." | 2.52 | Efficacy and safety of morniflumate for the treatment of symptoms associated with soft tissue inflammation. ( Cavalieri, L; Cremonesi, G, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Vivier, D | 1 |
| Bennis, K | 1 |
| Lesage, F | 1 |
| Ducki, S | 1 |
| Li, L | 2 |
| Zhang, M | 2 |
| Jia, D | 2 |
| Liu, Z | 2 |
| Zhang, N | 2 |
| Sun, B | 2 |
| Wang, Z | 2 |
| Liu, M | 2 |
| Wang, Q | 2 |
| Ganai, SA | 1 |
| Rajamanikandan, S | 1 |
| Shah, BA | 1 |
| Lone, A | 1 |
| Arwa, F | 1 |
| Malik, FA | 1 |
| Cremonesi, G | 2 |
| Cavalieri, L | 1 |
| Zhou, Y | 1 |
| Shapiro, M | 1 |
| Dong, Q | 1 |
| Louahed, J | 1 |
| Weiss, C | 1 |
| Wan, S | 1 |
| Chen, Q | 1 |
| Dragwa, C | 1 |
| Savio, D | 1 |
| Huang, M | 1 |
| Fuller, C | 1 |
| Tomer, Y | 1 |
| Nicolaides, NC | 1 |
| McLane, M | 1 |
| Levitt, RC | 2 |
| Hauber, HP | 1 |
| Goldmann, T | 1 |
| Vollmer, E | 1 |
| Wollenberg, B | 1 |
| Hung, HL | 1 |
| Zabel, P | 1 |
| Buritova, J | 1 |
| Chapman, V | 1 |
| Honoré, P | 1 |
| Besson, JM | 1 |
| Wheeler, MA | 1 |
| Yoon, JH | 1 |
| Olsson, LE | 1 |
| Weiss, RM | 1 |
| Tarantino, V | 1 |
| Stura, M | 1 |
2 reviews available for niflumic acid and Inflammation
| Article | Year |
|---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Struc | 2016 |
Efficacy and safety of morniflumate for the treatment of symptoms associated with soft tissue inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Hum | 2015 |
1 trial available for niflumic acid and Inflammation
| Article | Year |
|---|---|
[Niflumic acid in otorhynolaryngologic inflammation in childhood. Controlled study versus feprazone].
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Female; Feprazone; Humans; Infant; In | 1985 |
7 other studies available for niflumic acid and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Multi-specific niflumic acid platinum(IV) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; DNA Damage; Humans; Inflammation; Neo | 2022 |
Multi-specific niflumic acid platinum(IV) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; DNA Damage; Humans; Inflammation; Neo | 2022 |
Multi-specific niflumic acid platinum(IV) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; DNA Damage; Humans; Inflammation; Neo | 2022 |
Multi-specific niflumic acid platinum(IV) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; DNA Damage; Humans; Inflammation; Neo | 2022 |
Comparative structural study of selective and non-selective NSAIDs against the enzyme cyclooxygenase-2 through real-time molecular dynamics linked to post-dynamics MM-GBSA and e-pharmacophores mapping.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Cyclooxygenase 2; Humans; Inflammation; | 2023 |
A calcium-activated chloride channel blocker inhibits goblet cell metaplasia and mucus overproduction.
Topics: Amino Acid Sequence; Animals; Bronchoalveolar Lavage Fluid; Cells, Cultured; Chloride Channels; Cros | 2002 |
LPS-induced mucin expression in human sinus mucosa can be attenuated by hCLCA inhibitors.
Topics: Adult; Cell Line; Chloride Channels; Female; Flow Cytometry; Gene Expression Regulation; Humans; Imm | 2007 |
Interactions between NMDA- and prostaglandin receptor-mediated events in a model of inflammatory nociception.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Dose-Response Relationship, Drug; Exc | 1996 |
Cyclooxygenase-2 protein and prostaglandin E(2) production are up-regulated in a rat bladder inflammation model.
Topics: Administration, Intravesical; Animals; Blotting, Western; Cyclooxygenase 1; Cyclooxygenase 2; Cycloo | 2001 |